VivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testing

VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced the availability of an AI ...

Natural Component From Licorice Shows Promise for Treating Inflammatory Bowel Disease

A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.
Seeking Alpha

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (VIVS) (the “Company” or “VivoSim”) announced today that its NAMkind™ platform for intestinal efficacy prediction was recognized with a ...
EurekAlert!

Natural component from licorice alleviates inflammatory bowel disease in stem cell-based model and in animals

A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be ...
News-Medical.Net

Stem cell model identifies promising therapy for inflammatory bowel disease

A new study published today in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), ...
Medindia

Can a Natural Licorice Compound Finally Treat IBD?

Glycyrrhizin, a natural licorice compound, significantly reduces intestinal inflammation and cell death, offering fresh hope ...
BioTechniques

Drug discovery: relevance of 3D small intestine tissue model, EpiIntesinal™

In this White Paper, MatTek, now part of Sartorius, details a highly differentiated 3D small-intestine tissue model that uses primary human stem cells to provide a more accurate alternative to animal ...